Global Bioabsorbable Stents Industry: Key Statistics and Insights in 2024-2032
Summary:

The global bioabsorbable stents market size reached USD 409.4 Million in 2023.
The market is expected to reach USD 764.2 Million by 2032, exhibiting a growth rate (CAGR) of 7% during 2024-2032.
North America leads the market, accounting for the largest bioabsorbable stents market share.
Polymer-based bioabsorbable stents make up most of the market share in the biomaterial segment.
Slow-absorption stents hold the largest share in the bioabsorbable stents industry.
Coronary artery disease has the biggest market share due to its high prevalence, which drives the need for advanced treatments like bioabsorbable stents.
Hospitals are the leading end-user segment.
The increasing prevalence of cardiovascular diseases is a key driver of the bioabsorbable stents market.
Advances in stent technology and growing awareness of less invasive procedures are reshaping the bioabsorbable stents market.

Industry Trends and Drivers:

Increasing prevalence of cardiovascular diseases:

With heart disease as a leading cause of death worldwide, there is a high need for advanced treatment options. Traditional metal stents are effective but carry risks like long-term inflammation, thrombosis, and restenosis. Bioabsorbable stents provide a modern alternative by offering the support needed to reopen blocked arteries while gradually dissolving over time. This minimizes the risks of permanent implants. This feature appeals to both patients and healthcare providers who want safer, less invasive treatment solutions. The rising cases of heart disease, fueled by aging populations, sedentary lifestyles, and unhealthy diets, are driving demand for bioabsorbable stents.

Advancements in stent technology:

Manufacturers are investing in research and development to create next-generation bioabsorbable stents that outperform earlier models. These improvements include better flexibility, durability, and drug-eluting capabilities, which aim to enhance arterial support and reduce complications like restenosis and thrombosis. Newer bioabsorbable stents are made from biodegradable materials that dissolve naturally within the body after maintaining blood flow. This eliminates the need for permanent implants and lowers the risk of long-term complications. Also, faster-absorbing and more effective stents are increasing healthcare providers' confidence in recommending them.

Growing awareness and preference for minimally invasive procedures:

Patients and healthcare providers are becoming more informed about the benefits of minimally invasive procedures, leading to the adoption of bioabsorbable stents. Unlike traditional metal stents, bioabsorbable stents enable quicker recovery, less scarring, and a lower risk of long-term complications. These benefits attract patients seeking safer, less intrusive treatment options. Healthcare systems are also focusing on cost-effective treatments that cut the need for repeat interventions, long hospital stays, or extensive follow-up care. Bioabsorbable stents gradually dissolve after the artery heals, reducing further complications and making them a favored choice for doctors and patients.
Request for a sample copy of this report: https://www.imarcgroup.com/bioabsorbable-stents-market/requestsample
Bioabsorbable Stents Market Report Segmentation:
Breakup By Biomaterial:

Polymer-based Bioabsorbable Stents
Metal-based Bioabsorbable Stents

Polymer-based bioabsorbable stents exhibit a clear dominance in the market accredited to their superior flexibility and biocompatibility, which minimize the risk of arterial irritation and promote better healing.
Breakup By Absorption Rate:

Slow-Absorption Stents
Fast-Absorption Stents

Slow-absorption stents represent the largest segment, as they provide prolonged support to the artery, reducing the likelihood of vessel recoil and late thrombosis.
Breakup By Region:

North America (United States, Canada)
Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
Latin America (Brazil, Mexico, Others)
Middle East and Africa

North America dominates the market owing to the existence of an advanced healthcare infrastructure and the presence of leading device manufacturers in the region.
Top Bioabsorbable Stents Market Leaders:
The bioabsorbable stents market research report outlines a detailed analysis of the competitive landscape, offering in-depth profiles of major companies. Some of the key players in the market are:

Abbott Laboratories
Arterius Limited
B. Braun SE
Biotronik SE & Co. KG
Boston Scientific Corporation
Elixir Medical Corporation
Kyoto Medical Planning Co. Ltd.
Lepu Medical Technology (Beijing) Co. Ltd.
Meril Life Sciences Pvt. Ltd.
Reva Medical LLC
Terumo Corporation

If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.
About Us:
IMARC Group is a global management consulting firm that helps the world’s most ambitious changemakers to create a lasting impact. The company provide a comprehensive suite of market entry and expansion services. IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.
Contact Us:
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
United States: +1-631-791-1145

Items